Crystalline form of bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino)pyrimidin5-yl](3R,5S)-3,5-dihydroxyhept-6 - enoicacid] calcium salt

Details for Australian Patent Application No. 2004270467 (hide)

International Classifications

Event Publications

23 March 2006 PCT application entered the National Phase

PCT publication WO2005/023779 Priority application(s): WO2005/023779

21 August 2008 Application Accepted

Published as AU-B-2004270467

18 September 2008 Corrigenda

Applications Accepted - Name Index Under the name AstraZeneca UK Limited, Application No. 2004270467, under INID(54), correct the invention title to Crystalline form of bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]py rimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6 -enoicacid] calcium salt

18 December 2008 Standard Patent Sealed

19 January 2012 Licence Registered

AstraZeneca UK Limited ( AstraZeneca Pty Ltd )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.